4.6 Article

Beta-blockers for coronary heart disease in chronic kidney disease

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

Beta blockers in the management of chronic kidney disease

G. L. Bakris et al.

KIDNEY INTERNATIONAL (2006)

Review Urology & Nephrology

Sympathetic hyperactivity in chronic renal failure: A wake-up call

HA Koomans et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)

Article Medicine, General & Internal

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease

P Muntner et al.

ANNALS OF INTERNAL MEDICINE (2004)

Article Urology & Nephrology

Drug therapy for hypertension in hemodialysis patients

MP Hörl et al.

SEMINARS IN DIALYSIS (2004)

Article Cardiac & Cardiovascular Systems

Task force 1: The ACCF and AHA codes of conduct in human subjects research

RJ Adams et al.

CIRCULATION (2004)

Article Medicine, General & Internal

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report

AV Chobanian et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Cardiac & Cardiovascular Systems

Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy -: A prospective, placebo-controlled trial

G Cice et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)

Article Urology & Nephrology

Goodpasture syndrome during the course of a Schonlein-Henoch purpura:

L Carreras et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2002)